Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Long Term Incentive Plan 2024 Performance Share Awards Paris, France, and Eastleigh and Manchester, UK – 23 April 2024 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM:...

Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Full Year Trading update Integration of Yourgene Health plc ahead of schedule Paris, France, and Eastleigh and Manchester, UK – 25 January 2024 – Novacyt S.A....

Novacyt S.A. (“Novacyt”, the “Company” or the “Group”) Appointment of CFO Paris, France, and Eastleigh and Manchester, UK – 2 January – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics...

Paris, France, Eastleigh and Manchester, UK – 21 December 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and...

Paris, France, and Eastleigh UK – 26 October 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that all resolutions proposed at the...

Paris, France, and Eastleigh UK – 11 October 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that shareholders are now able to...